Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 12 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Zografou, Ioanna  [Clear All Filters]
Journal Article
Athyros, V. G., Sachinidis A. G., Zografou I., Simoulidou E., Piperidou A., Stavropoulos N., et al. (2018).  Boosting the Limited Use of Mineralocorticoid Receptor Antagonists Through New Agents for Hyperkalemia.. Curr Pharm Des. 24(46), 5542-5547.
Papadopoulou, E., Loutradis C., Tzatzagou G., Kotsa K., Zografou I., Minopoulou I., et al. (2020).  Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.. J Hypertens.
Papadopoulou, E., Theodorakopoulou M. P., Loutradis C., Tzanis G., Tzatzagou G., Kotsa K., et al. (2021).  Dapagliflozin Does Not Affect Short-Term Blood Pressure Variability in Patients With Type 2 Diabetes Mellitus.. Am J Hypertens. 34(4), 404-413.
Georgianou, E., Georgianos P. I., Petidis K., Markakis K., Zografou I., & Karagiannis A. (2019).  Effect of Nebivolol and Olmesartan on 24-Hour Brachial and Aortic Blood Pressure in the Acute Stage of Ischemic Stroke.. Int J Hypertens. 2019, 9830295.
Sambanis, C., Tziomalos K., Kountana E., Kakavas N., Zografou I., Balaska A., et al. (2008).  Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes.. Acta Diabetol. 45(1), 23-30.
Zografou, I., Sampanis C., Gkaliagkousi E., Iliadis F., Papageorgiou A., Doukelis P., et al. (2015).  Effect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus.. Hormones (Athens). 14(1), 118-25.
Patoulias, D., Stavropoulos K., Imprialos K., Katsimardou A., Kalogirou M-S., Koutsampasopoulos K., et al. (2019).  Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of RCTs.. Diabetes Res Clin Pract. 158, 107927.
Nikolaidou, B., Gkaliagkousi E., Anyfanti P., Gavriilaki E., Lazaridis A., Triantafyllou A., et al. (2020).  The impact of hyperglycemia on urinary albumin excretion in recent onset diabetes mellitus type II.. BMC Nephrol. 21(1), 119.
Patoulias, D., Doumas M., Kotsis V., Stavropoulos K., Imprialos K., Zografou I., et al. (2019).  Liraglutide as adjunct to insulin treatment in patients with type 1 diabetes: A systematic review and meta-analysis.. Curr Diabetes Rev.
Imprialos, K. P., Stavropoulos K., Doumas M., Skalkou A., Zografou I., & Athyros V. G. (2018).  The potential role of statins in treating liver disease.. Expert Rev Gastroenterol Hepatol. 12(4), 331-339.
Patoulias, D., Papadopoulos C., Stavropoulos K., Zografou I., Doumas M., & Karagiannis A. (2020).  Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors.. J Clin Hypertens (Greenwich).
Patoulias, D., Manafis A., Mitas C., Avranas K., Lales G., Zografou I., et al. (2018).  Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice.. Cardiovasc Hematol Disord Drug Targets. 18(2), 139-146.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές